In a significant move to bolster healthcare infrastructure, the Challa Group has proudly announced a new partnership with international entities to develop a cutting-edge cancer center in Andhra Pradesh. This ambitious project involves collaborations with the World Smart Cities Forum (WSCF) from South Korea, as well as firms from the USA, UK, and iHolding, UK.
A formal Letter of Intent (LOI) was recently signed in Vijayawada, bringing together five key partner companies committed to the center’s construction. This builds upon an earlier Memorandum of Understanding (MoU) established between the Challa Group and WSCF, setting the foundation for this transformative initiative.
The envisioned cancer center will span an impressive 25 acres, with its precise location to be determined following further discussions and approvals from the State government.
Adding another critical layer to this healthcare initiative, OMEXA Biologics (OMEXA) has partnered with WSCF to integrate a dedicated cancer drug production facility directly within the hospital premises. This will ensure local availability and potentially reduce costs for vital cancer treatments.
Beyond healthcare, the Challa Group is also driving economic growth by establishing a comprehensive industrial park in Donakonda, reflecting a broader commitment to regional development.